About this trial
Evaluate the effect of High-Intensity Focused Electromagnetic Therapy on pain, quadriceps strength, and quality of life in patients with patellofemoral pain syndrome
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of patellofemoral pain syndrome (anterior or peripatellar knee pain aggravated by at least two activities such as stair climbing, prolonged sitting, squatting, or running).
Symptoms persisting for at least 3 months.
Disqualifiers
History of previous knee surgery or trauma (e.g., ligamentous laxity, meniscal tear, or patellar fracture).
Concomitant knee pathology (e.g., tibiofemoral osteoarthritis, patellar tendinopathy, or plica syndrome).
Presence of metallic implants, pacemakers, or electrical medical devices in the body .
Recent corticosteroid or hyaluronic acid injection into the affected knee within the last 3 months.
Trial design
Parallel
Treatments tested in this trial
True High-Intensity Focused Electromagnetic Therapy
Device20-30 minute sessions, 2-3 times per week for 8 weeks at a clinically effective, tolerable intensity level designed to elicit supramaximal contractions for the quadriceps muscle.
Sham High-Intensity Focused Electromagnetic Therapy
DeviceThe device protocol, application time, and acoustic feedback will the same as the experimental arm, but with the device in the off state and no muscular contractions in the quadriceps muscle .
Traditional Physiotherapy
Other interventionStandard rehabilitation program including patellar mobilization with quadriceps and hip abductor strengthening.
Treatment groups
Trial outcomes
Primary outcomes
Pain level
Visual Analog Scale will be used to assess pain
Secondary outcomes
Quadriceps muscle strength
Isokinetic dynamometry will be used for assessing quadriceps muscle strength
Health-related quality of life
Short Form-12 Health Survey (SF-12) will be used to assess QoL
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: